The present invention relates to a method of preparing a cancer vaccine, wherein tumor cells are fused with either dendritic cells, or lymphocytes B or T, said cancer cells may be modified in order to alter the expression of a major determinant of said cancer. The invention also relates to a vaccine composition comprising the hybridomas obtained with said method.
